Isaguliants Maria G, Trotsenko Ivan, Buonaguro Franco M
Riga Stradins University, Riga, Latvia.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Infect Agent Cancer. 2022 Jul 8;17(Suppl 2):28. doi: 10.1186/s13027-022-00436-0.
This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium "Chronic viral infection and cancer, openings for vaccines" virtually held on December 16-17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.
这是一份关于病毒学、肿瘤学以及病毒相关癌症领域当前正在进行的研究活动的报告，以及关于通过疫苗和免疫疗法对其进行治疗和预防的可能性的报告，这些内容在2021年12月16日至17日以线上形式举办的“慢性病毒感染与癌症，疫苗的契机”研讨会上有所概述。参与实体瘤与病毒之间复杂关系研究的各学科专家齐聚一堂，讨论该领域的最新进展，并汇报他们在特定主题上的个人贡献。次要终点是维持2016年成立的TECHVAC网络，该网络是一个多学科工作小组，专门致力于开发针对慢性病毒感染及相关癌症的疫苗和免疫疗法，旨在确定共同感兴趣的领域，促进研究合作，建立跨境合作项目，并协调临床和研究活动。
